(Unaudited data)
- CUMULATIVE ACTIVITY AS OF THE END OF JUNE 2014
| In thousands of euros | 2013 | 2014 | Variation at current exchange rates | Variation at constant exchange rates |
| France | 159,597 | 157,018 | - 1.6% | - 1.6% |
| International : | 116,187 | 104,598 | - 10.0% | - 7.0% |
| Incl. Europe (excluding France) | 83,381 | 73,537 | - 11.8% | - 9.6% |
| Incl. North America | 25,579 | 23,287 | - 9.0% | - 3.7% |
| Incl. Other countries | 7,227 | 7,774 | + 7.6% | + 11.2% |
| Group Total | 275,784 | 261,616 | - 5.1% | - 3.9% |
| In thousands of euros | 2013 | 2014 | Variation at current exchange rates | Variation at constant exchange rates |
| Non-proprietary Homeopathic Medicines | 152,097 | 150,991 | - 0.7% | - 0.4% |
| OTC Specialties | 123,466 | 110,254 | - 10.7% | - 8.3% |
| Other | 221 | 371 | + 67.9% | + 59.7% |
| Group Total | 275,784 | 261,616 | - 5.1% | - 3.9% |
- ACTIVITY IN THE QUARTER (variation at current rate)
| In thousands of euros | 1s t Quarter | 2nd Quarter | ||||
| 2013 | 2014 | Var. | 2013 | 2014 | Var. | |
| France | 84,270 | 82,749 | -1.8% | 75,327 | 74,269 | -1.4% |
| International : | 73,751 | 57,460 | -22.1% | 42,436 | 47,138 | + 11.1% |
| Incl. Europe (excluding France) | 54,334 | 39,967 | -26.4% | 29,047 | 33,570 | + 15.6% |
| Incl. North America | 15,562 | 12,662 | -18.6% | 10,017 | 10,625 | + 6.1% |
| Incl. Other countries | 3,855 | 4,831 | + 25.3% | 3,372 | 2,943 | -12.7% |
| Group Total | 158,021 | 140,209 | - 11.3% | 117,763 | 121,407 | +3.1% |
| In thousands of euros | 1st Quarter | 2nd Quarter | ||||
| 2013 | 2014 | Var. | 2013 | 2014 | Var. | |
| Non-proprietary Homeopathic Medicines | 79,062 | 77,919 | -1.4% | 73,035 | 73,072 | + 0.1% |
| OTC Specialties | 78,866 | 62,196 | -21.1% | 44,600 | 48,058 | + 7.8% |
| Other | 93 | 94 | + 1.1% | 128 | 277 | + 116.4% |
| Group Total | 158,021 | 140,209 | - 11.3% | 117,763 | 121,407 | +3.1% |
2014 SECOND QUARTER HIGHLIGHTS
Sales in the second quarter of 2014 increased by 3.1% compared to the second quarter of 2013.
Income in the first half of 2014 should be lower than the first half of 2013 which benefited from exceptionally high business volume.
At June 30, 2014, the group's cash amounted to approximately 140 million euros.
Given the uncertainty of seasonal illnesses in the second half-year period, the group confirms its cautiousness regarding 2014.
Our next update:
August 29, 2014: at market close, publication of 2014 half-year results.
Person responsible for financial information: Christian Boiron
Contact for financial information: Véronique Bouscayrol
Investor relations: +33 (0) 4.78.45.63.43 - e-mail : finances@boiron.fr
ISIN Code: FR0000061129 (BOI) - Bloomberg : BOI FP - Reuters : BOIR.PA
The group's financial information is online at: www.boiron.com
Communiqués au titre de l'obligation d'information permanente :
- Communiqué sur comptes, résultats, chiffres d'affaires Communiqué intégral et original au format PDF :
http://www.actusnews.com/documents_communiques/ACTUS-0-36620-cp-boiron-150714.pdf
0 commentaire
Vous devez être membre pour ajouter un commentaire.
Vous êtes déjà membre ? Connectez-vous
Pas encore membre ? Devenez membre gratuitement
Signaler le commentaire
Fermer